Metropolis Healthcare - Inorganic Foray into Non-Core Markets; Scalability Key Monitorable
MHL announced its acquisition of Core Diagnostics—an oncology focused diagnostics chain with majority of its revenue derived from North/East India—...
219 Views
Metropolis Healthcare: Core Diagnostic M&A to Strengthen Speciality Portfolio.
Metropolis signed a definite agreement to acquire a 100% stake in Core Diagnostics. This acquisition will strengthen its advanced cancer testing...
191 Views
Metropolis Healthcare - Tier 3 Expansion and Wellness Portfolio to Drive Revenue Growth
MHL’s Q2FY25 print was in line with our estimates, with revenues growing 13% YoY, driven by B2C revenues improving 21% YoY.
80 Views
APAC Healthcare Weekly (Dec 15)-Daiichi Sankyo, Eisai, Celltrion, Metropolis Healthcare, CSPC Pharma
The insight covers key developments in prominent APAC healthcare companies. These developments are expected to impact the financials of the...
287 Views
# 72 India Insight: VI Preferential Issue, JSW Production Growth, Metropolis Acquisition of Core
JSW Steel sees production growth, Vodafone Idea to raise funds through Preferential issue, Metropolis Healthcare acquires Core Diagnostics.
269 Views